Bryan Mazlish
Direktor/Vorstandsmitglied bei CHARDAN NEXTECH ACQUISITION CORP.
Profil
Bryan Mazlish is the founder of Overlook Capital LLC (founded in 2005), Bigfoot Biomedical, Inc. (founded in 2014), and Surf Bio, Inc. (founded in 2021).
He is currently an Independent Director at Chardan Nextech Acquisition Corp.
Mr. Mazlish previously served as the Chief Executive Officer of PhysioLogic Devices, Inc. in 2020.
He completed his undergraduate degree at Harvard College.
Aktive Positionen von Bryan Mazlish
Unternehmen | Position | Beginn |
---|---|---|
CHARDAN NEXTECH ACQUISITION CORP. | Direktor/Vorstandsmitglied | - |
Bigfoot Biomedical, Inc.
Bigfoot Biomedical, Inc. Medical SpecialtiesHealth Technology Bigfoot Biomedical, Inc. operates as a health solution company. It focuses on optimizing the care of people with Type 1 Diabetes (T1D). The firm develops an automated insulin delivery solution for the management of T1D based on cloud connectivity and human-centered-automation. The company was founded by Jeffrey S. Brewer, Jon Brilliant, Bryan Mazlish and Lane Desborough in November 2014 and is headquartered in Milpitas, CA. | Gründer | 01.11.2014 |
Surf Bio, Inc.
Surf Bio, Inc. Pharmaceuticals: MajorHealth Technology Surf Bio, Inc. is a preclinical biopharmaceutical company that develops enhanced therapeutic solutions for various therapeutic areas, including diabetes, oncology, infectious diseases, and gene therapy. The company is based in Palo Alto, CA, and was founded by Jennifer Schneider and Bryan Mazlish. The company leverages a novel biotechnology platform and a breakthrough drug stabilization technology developed in the Appel lab. The technology enables a reduction of refrigeration requirements, transition from IV to subcutaneous therapy, and novel pharmaceutical formulations. Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC. Bryan Mazlish has been the CEO since incorporation. | Gründer | 01.01.2021 |
Ehemalige bekannte Positionen von Bryan Mazlish
Unternehmen | Position | Ende |
---|---|---|
PhysioLogic Devices, Inc.
PhysioLogic Devices, Inc. Medical SpecialtiesHealth Technology PhysioLogic Devices, Inc. provides treatment for people with type 1 diabetes. It develops implantable intraperitoneal closed-loop artificial pancreas which eliminates the need for testing blood sugars and taking insulin through the skin. The company was founded by Peter Lord and is headquartered in Alpine, CA. | Vorstandsvorsitzender | 01.10.2020 |
Overlook Capital LLC | Gründer | 01.01.2012 |
Ausbildung von Bryan Mazlish
Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Overlook Capital LLC | |
Bigfoot Biomedical, Inc.
Bigfoot Biomedical, Inc. Medical SpecialtiesHealth Technology Bigfoot Biomedical, Inc. operates as a health solution company. It focuses on optimizing the care of people with Type 1 Diabetes (T1D). The firm develops an automated insulin delivery solution for the management of T1D based on cloud connectivity and human-centered-automation. The company was founded by Jeffrey S. Brewer, Jon Brilliant, Bryan Mazlish and Lane Desborough in November 2014 and is headquartered in Milpitas, CA. | Health Technology |
PhysioLogic Devices, Inc.
PhysioLogic Devices, Inc. Medical SpecialtiesHealth Technology PhysioLogic Devices, Inc. provides treatment for people with type 1 diabetes. It develops implantable intraperitoneal closed-loop artificial pancreas which eliminates the need for testing blood sugars and taking insulin through the skin. The company was founded by Peter Lord and is headquartered in Alpine, CA. | Health Technology |
Chardan Nextech Acquisition Corp.
Chardan Nextech Acquisition Corp. Financial ConglomeratesFinance Chardan Nextech Acquisition Corp. operates as a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on June 23, 2020 and is headquartered in New York, NY. | Finance |
Surf Bio, Inc.
Surf Bio, Inc. Pharmaceuticals: MajorHealth Technology Surf Bio, Inc. is a preclinical biopharmaceutical company that develops enhanced therapeutic solutions for various therapeutic areas, including diabetes, oncology, infectious diseases, and gene therapy. The company is based in Palo Alto, CA, and was founded by Jennifer Schneider and Bryan Mazlish. The company leverages a novel biotechnology platform and a breakthrough drug stabilization technology developed in the Appel lab. The technology enables a reduction of refrigeration requirements, transition from IV to subcutaneous therapy, and novel pharmaceutical formulations. Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC. Bryan Mazlish has been the CEO since incorporation. | Health Technology |